The 91st CMEF: Shanghai Sun Biotech's Coagulation Products Attract Global Attention

        From April 8 to 11, 2025, the 91st China International Medical Equipment Fair (CMEF) was held at the Shanghai National Convention and Exhibition Center. With the theme of "Innovative Technology, Leading the Future", this expo attracted nearly 5,000 companies from more than 30 countries and regions to participate in the exhibition, with a total of more than 200,000 professional visitors. Shanghai Sun Biotech exhibited a whole series of coagulation products, demonstrating the innovative strength and globalization strategy of China's coagulation detection technology to the domestic and foreign medical community.

UG2500 Coagulation Analyzer

        During the exhibition, the UG2500 automated coagulation analyzer exhibited by Shanghai Sun Biotech became the focus of professionals' attention. The product integrates multiple detection methods such as optical, mechanical, and platelet aggregation test, and can simultaneously detect coagulation function and platelet aggregation function, realizing comprehensive detection of primary and secondary hemostasis. By intelligently switching detection modes, UG2500 can effectively address complex sample interference such as hemolysis and lipemia. Its trace detection function greatly improves the applicability in detecting samples from pediatric patients and patients with difficulty in blood collection, providing precise solutions for diverse clinical scenarios around the world.

UL-2000LAS Laboratory Automation System

       The UL-2000LAS Laboratory Automation System integrates AI sample quality identification, single-tube RFID tracking, on-track sampling, dual emergency sample management, and other advanced technologies. Equipped with the UR series coagulation analysis module, it achieves full process automation with a maximum detection throughput of 900 tests/hour. Its modular design (standard pre-treatment occupies less than 2 m2) can flexibly adapt to the needs of medical institutions of different sizes, demonstrating the international competitiveness of China's coagulation detection technology.

25 years of technological accumulation, winning the trust of global customers

       Shanghai Sun Biotech has been deeply involved in the field of thrombosis and hemostasis diagnosis for 25 years. Backed by strong independent R&D and rich technical accumulation, it has built a comprehensive coagulation diagnosis product system. Its high-end coagulation analyzers are widely used in clinical diagnosis in tertiary hospitals, and have won high recognition from global users with their excellent performance. The company's product service network has covered more than 30 countries around the world. At the 91st CMEF Expo, our company fully demonstrated the application advantages of its products in different medical environments through a themed scenario roadshow, attracting many domestic and foreign medical institutions and distributors to explore cooperation.

       Shanghai Sun Biotech adheres to the concept of "Creating Products for Life", continues to increase R&D investment, and is committed to promoting advanced domestic coagulation detection products to the global market, benefiting more people, and contributing wisdom and strength to the global medical and health industry.

(About Shanghai Sun Biotech Co.,Ltd)

       Shanghai Sun Biotech Co., Ltd. was established in 2001 and focuses on the field of thrombosis and hemostasis diagnosis. It is a mainstream supplier of thrombosis and hemostasis overall solutions in the world. The company adheres to the concept of "creating products for life" and is committed to the research and development, production and sales of thrombosis and hemostasis diagnostic reagents, medical instruments, and medical consumables.

       The company strictly adheres to the quality management system and has passed the dual certifications under the international quality systems ISO9001 and ISO13485. The company's core products all have independent intellectual property rights, with more than 100 patents in total. At the same time, it actively participates in the formulation of national industry standards such as PT, APTT, TT, FIB, D-Dimer, Anti-Xa and coagulation analyzers, and promotes the standardization of coagulation detection technology. The company has successively obtained many honorary qualifications such as the "Little Giant" enterprise of the Ministry of Industry and Information Technology, the national high-tech enterprise, the Shanghai Science and Technology Little Giant Enterprise, and the 100 smart factories in Shanghai.

       Moving forward, Shanghai Sun Biotech will continue to deepen its expertise in thrombosis and hemostasis, driving product innovation consistently to deliver professional diagnostic solutions to global customers, and contribute to the development of global healthcare industry.